Publications Office of the EU
Supply of medicines - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates CPV codes deduced from the text of the procedure

- indicates text translated automatically in your browsing language

Supply of medicines Text automatically translated in your browsing language Automatically translated

  • Published
    12/06/2025
  • Deadline
    15/07/2025
  • Today
    15/07/2025
  • Opening of tenders
    15/07/2025
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
Szpital Specjalistyczny Ducha Świętego w Sandomierzu
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: PL722 Sandomiersko-jędrzejowski
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Number of lots
80
Tender reference number
PN/8/2025
Description

The subject of the contract is the successive delivery of medicines: 1. Immunoglobulinum humanum normale (IgG) – Medicinal programme B.67. – Package 1, 2. Ofatumumabum - The drug program B.29. – Package 2, 3. Teriflunomideum - The drug program B.29. – Package 3, 4. Certolizumab pegol - Drug programs B.33., B.35., B.36., B.82. – Package 4, 5. Tolvaptanum - The drug program B.126. – Package 5, 6. Tolvaptanum - The drug program B.126. – Package 6, 7. Tolvaptanum - The drug program B.126. – Package 7, 8. Peginterferon beta-1a - The drug program B.29. – Package 8, 9. Roxadustatum - The drug program B.37. – Package 9, 10. Dimethylis fumaras - The drug program B.29. – Package 10, 11. Etanerceptum - Medication programs: B.33., B.35., B.36., B.82. – Package Nos 11 and 12. Adalimumabum - Medication programs: B.33, B.35, B.36. – Package Nos 12 and 13. Toxinum botulinicum type A ad iniectabile - Drug programs: B.28., B.57. - Parcel No. 13, 14. Siponimodum - Medication program B.29. – Package No 14, 15. Siponimodum - Medication program B.29. – Package No 15, 16. Siponimodum - Medication program B.29. – Package 16, 17. Toxinum botulinicum type A ad iniectabile - Drug programs: B.28., B.57., B.133. – Package 17, 18. Darbepoetinum alfa - The drug program B.37. – Package No 18, 19. Fingolimodum - Medication program B.29. – Package 19, 20. Interferon beta-1a - The drug program B.29. – Package 20, 21. Interferon beta-1a - The drug program B.29. – Package No 21, 22. Ixekizumabum - Medication programs: B.35.; B.36.; B.82. – Package No 22, 23. Avalglucosidasum alfa - The drug program B.22. – Package No 23, 24. Bimekizumabum - Medication programs: B.35.; B.36.; B.82. – Package No 24, 25. Romosozumabum - Medication program: B.160. – Package No 25, 26. Ravulizumabum - Medication program: B.157. – Package 26, 27. Alteplasum – Package 27, 28. Medicinal products – Package No 28, 29. Medicinal products – Package No 29, 30. Psychotropic and intoxicating drugs – Package 30, 31. Medicinal products – Package No 31, 32. Methylprednisolonum – Package No 32, 33. Medicinal products – Package 33, 34. Medicinal products – Package No 34, 35. Medicinal products – Package No 35, 36. Medicinal products – Package 36, 37. Medicinal products – Package 37, 38. Medicinal products – Package 38, 39. Antibiotics – Package 39, 40. BCG – Package 40, 41. Prothrombinum multiplex – Package 41, 42. Linezolidum – Package 42, 43. Matrixes – Package 43, 44. Sevofluranum – Package No 44, 45. Rocuronium – Package 45, 46. Medicinal products – Package 46, 47. Medicinal products – Package 47, 48. Denatured alcohol – Package 48, 49. Medicinal products – Package 49, 50. Albumin – Package 50, 51. Medicinal products – Package No 51, 52. Medicinal products – Package No 52, 53. Medicinal products – Package No 53, 54. Aqua pro irrigatione – Package 54, 55. Natrium chloratum solution for irrigation – Package Nos 55, 56. Poractantum alfa – Package No 56, 57. Medicinal products – Package 57, 58. Eptifibatidum – Package 58, 59. Meropenemum – Package 59, 60. Medicinal products – Package No 60, 61. Medicinal products – Package No 61, 62. Medicinal products – Package 62, 63. Medicinal products – Package No 63, 64. Medicinal products – Package No 64, 65. Andexanetum alfa – Package Nos 65, 66. Medicinal products – Package 66, 67. Port needles – Package 67, 68. Probiotic – Package 68, 69. Medicinal products – Package No 69, 70. Enoxaparinum natricum – Package No 70, 71. Olanzapinum – Package 71, 72. Oseltamivirum – Package 72, 73. Initial milk – Package No 73, 74. Nutrition – Package 74, 75. Nutrition – Package 75, 76. Nutrition and Medicinal Products – Package 76, 77. Medicinal products – Package 77, 78. Liquids and nutrition – Package 78, 79. Complex medicinal products – Package No 79, 80. Rivaroxabanum – Package 80. Detailed Description of the Subject of the Order is contained in Annex No. 1 to the SWZ. Text automatically translated in your browsing language Automatically translated

Submission Method
Electronic via:
https://ezamowienia.gov.pl/mp-client/tenders/ocds-148610-7402c74c-8c2d-429f-b568-164f3129d96f
Tenders may be submitted
Electronic submission: required
https://ezamowienia.gov.pl/mp-client/tenders/ocds-148610-7402c74c-8c2d-429f-b568-164f3129d96f
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
15/07/2025 08:30
CPV code

33600000 - Pharmaceutical products

33690000 - Various medicinal products CVP code deduced from the text of the procedure AI-generated

Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.